Merus Announces Publication of Abstract on Zenocutuzumab in NRG1-fusion (NRG1+) Cancers at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Merus N V : Merus Announces Publication of Abstract on Zenocutuzumab in NRG1-fusion (NRG1+) Cancers at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
BK Technologies Announces First Quarter 2021 Results
ACCESSWIRE
13 May 2021, 22:31 GMT+10
WEST MELBOURNE, FL / ACCESSWIRE / May 13, 2021 / BK Technologies Corporation (NYSE American:BKTI) today announced financial and operating results for the first quarter ended March 31, 2021. The Company will host a conference call today, May 13, 2021, at 9:00 AM eastern time.
Recent Financial and Operational Highlights
Cost management initiatives offset revenue delays, related to the timing of certain orders from existing customers and supply chain constraints, that will benefit future quarters
New Technology Innovation Center in South Florida, focused on completing and launching the BKR 9000 multiband communications technology ( BKR 9000 ) for the public safety market
Received first pre-orders for BKR 9000 from new customers